Dorzolamide-timolol

DRUG2 trials

Sponsors

Wills Eye

Conditions

Age-related Macular DegenerationDiabetic Macular EdemaNeovascular Age-related Macular DegenerationRetinal Vein OcclusionWet Macular Degeneration

Phase 2

Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.

CompletedNCT02571972

Wills EyeAge-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion +1

Start: 2015-02-01End: 2015-12-20Updated: 2019-12-03

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

CompletedNCT03034772

Wills EyeNeovascular Age-related Macular Degeneration, Wet Macular Degeneration

Start: 2017-02-08End: 2019-07-05Updated: 2020-06-19

Related Papers

Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular Degeneration

JAMA Ophthalmology2020-04-0212 citations